Stocks of Ironwood Pharmaceuticals Inc (NASDAQ:IRWD) traded higher last session on Wall Street, up 9.14% to $6.09.
IRWD stock price is now -13.23% away from the 50-day moving average and -37.27% away from the 200-day moving average. The market capitalization of the company currently stands at $968.07M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $21, Craig Hallum recently initiated with Buy rating for Ironwood Pharmaceuticals Inc (NASDAQ: IRWD). On December 14, 2023, Wells Fargo recently initiated its ‘Overweight’ rating on the stock quoting a target price of $20, while ‘Jefferies’ rates the stock as ‘Buy’
In other news, McHugh Julie, Director sold 22,766 shares of the company’s stock on Jun 10 ’24. The stock was sold for $143,198 at an average price of $6.29. Upon completion of the transaction, the Director now directly owns 139,528 shares in the company, valued at $0.85 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Jun 07 ’24, Director Moukheibir Catherine sold 35,574 shares of the business’s stock. A total of $235,144 was realized by selling the stock at an average price of $6.61. This leaves the insider owning 48,633 shares of the company worth $0.3 million. A total of 2.50% of the company’s stock is owned by insiders.
During the past 12 months, Ironwood Pharmaceuticals Inc has had a low of $5.47 and a high of $15.70. The fifty day moving average price for IRWD is $6.9802 and a two-hundred day moving average price translates $9.69425 for the stock.
The latest earnings results from Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) was released for 2024-03-31. The net profit margin was -254.41% and return on equity was -559.14% for IRWD. The company reported revenue of $74.88 million for the quarter, compared to $104.06 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -28.05 percent.
